Keros therapeutics stock

Author: aovl

August undefined, 2024

WebOn average, Wall Street analysts predict that Keros Therapeutics 's share price could reach $101.67 by Mar 6, 2024. The average Keros Therapeutics stock price prediction forecasts a potential upside of 155.51% from the current KROS share price of $39.79. Web3 apr. 2024 · NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Split ... Keros Therapeutics. 1050 Waltham Street, Suite 302 Lexington, MA 02421 +1 (617) 314-6297.

Keros Therapeutics, Inc. (KROS) Stock Price, Quote

Web15 jul. 2024 · As the Insider of Keros Therapeutics, Inc., Dr. Lachey earned a total compensation package of $2,705,906.00 in 2024. Dr. Lachey earned a salary of $402,800.00, options awards of $2,101,166.00, non-equity compensation of $201,400.00, and other compensation of $540.00.The highest earning executive at Keros … Web20 mrt. 2024 · Keros Therapeutics Inc. stock price ended on $43.37 on Monday after gaining 1.86%(Updated on Mar 20, 2024) The Keros Therapeutics Inc. stock price gained 1.86% on the last trading day (Monday, 20th Mar 2024), rising from $42.58 to $43.37. During the last trading day the stock fluctuated 3.67% from a day low at $41.86 to a day high of … johnny silverhand theme

Keros Therapeutics Inc Stock Forecast, Predictions & Price Target

WebTrading Signals for Keros Therapeutics Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. ... Unique to Barchart.com, Opinions analyzes a … Web20 mrt. 2024 · The Keros Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human … Web22 uur geleden · Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for … johnny silverhand shoes cyberpunk

Keros Therapeutics - KROS Stock Forecast, Price & News

WebKeros Therapeutics started at buy with $100 stock price target at Truist Oct. 18, 2024 at 7:23 a.m. ET by Tomi Kilgore Keros Therapeutics sets IPO terms, expects to raise up … Web12 apr. 2024 · NASDAQ:KROS Keros Therapeutics - KROS News Today $40.14 +0.35 (+0.88%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $38.79 $40.67 50-Day Range $39.79 $59.32 52-Week Range $24.38 $68.29 Volume 310,559 shs Average Volume 253,296 shs Market Capitalization $1.15 billion P/E Ratio N/A Dividend Yield N/A Price … how to get smite 6 in hypixel skyblockWebLEXINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the … how to get smite 7 hypixel skyblock

"Web12 apr. 2024 · KROS Stock Overview. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments … " - Keros therapeutics stock

Keros therapeutics stock

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $106.25 …

Web22 uur geleden · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Keros Therapeutics (KROS) WebKeros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological, …

Did you know?

WebKeros Therapeutics (NASDAQ: KROS) is owned by 69.33% institutional shareholders, 36.96% Keros Therapeutics insiders, and 0.00% retail investors. Alon Lazarus is the largest individual Keros Therapeutics shareholder, owning 2.04M shares representing 7.14% of the company. Alon Lazarus's Keros Therapeutics shares are currently valued … Web13 apr. 2024 · Keros Therapeutics (NASDAQ:KROS) has a recorded net income of -$104.68 million. KROS has generated -$4.15 earnings per share over the last four …

Web31 dec. 2024 · Keros Therapeutics, Inc. announced that it will receive $10,000,078 in funding on April 15, 2016. The company will issue series A preferred share and series A-1 preferred share in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. © S&P Capital IQ 2016 All news about KEROS … Web24 mrt. 2024 · Keros Therapeutics, Inc. Common Stock (KROS) Stock Price, Quote, News & History Nasdaq Keros Therapeutics, Inc. Common Stock (KROS) Add to …

WebTrading Signals for Keros Therapeutics Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. ... Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, ... WebC/O KEROS THERAPEUTICS, INC. 1050 WALTHAM STREET, SUITE 302 (Street) LEXINGTON: MA: 02421 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Keros Therapeutics, Inc. [ KROS] 5. Relationship of Reporting Person(s) to Issuer ... Common Stock: 04/08/2024: M: 4,000: A $ 0.48: 252,856: D:

WebLEXINGTON, Mass., March 03, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery ...

Web29 mrt. 2024 · Keros Therapeutics Inc. (NASDAQ:KROS) is a stock that investors ... SPACInsider • 20 days ago Are analysts optimistic about UWM Holdings Corporation's (NYSE ... SPACInsider • 20 days ago Contrasting Mirion Technologies (MIR) & Its Peers SPACInsider • 20 days ago SVB Leerink Weighs in on Keros Therapeutics, Inc.'s Q2 … how to get smiley faces in outlook johnny silverhand x readerWebThe Keros team is growing across all functions and we are seeking collaborative and innovative colleagues who want to join our dynamic team. We want to hear from … johnny silverhand shoesWeb4 aug. 2024 · Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and musculoskeletal disorders with … johnny silverhands shoesWebFounded Date 2015. Founders Jasbir Seehra. Operating Status Active. Last Funding Type Series C. Legal Name Keros Therapeutics, Inc. Stock Symbol NASDAQ:KROS. Company Type For Profit. Phone Number (617)513-8774. Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel … how to get smileys on windows 10WebKeros Therapeutics, Inc. (KROS) Latest Stock News & Headlines - Yahoo Finance Keros Therapeutics, Inc. (KROS) NasdaqGM - NasdaqGM Real Time Price. Currency in USD … johnny silverhand vest locationWebLEXINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and... johnny silverhand vrchat avatar